BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 11586969)

  • 1. Hemophilia.
    Mariani G; Kroner BL; Brackmann HH
    N Engl J Med; 2001 Oct; 345(14):1066; author reply 1067. PubMed ID: 11586969
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunetolerance as treatment of alloantibodies to factor VIII in hemophilia. The International Registry of Immunetolerance Protocols.
    Mariani G; Scheibel E; Nogao T; Kasper CK; Ewing NP; Mauser-Bunschoten E; Ghirardini A; Bellocco R; Brackman HH
    Semin Hematol; 1994 Apr; 31(2 Suppl 4):62-4. PubMed ID: 7939781
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of immune tolerance with factor VIII concentrate in patients with hemophilia A and inhibitors.
    Ewing NP
    Prog Clin Biol Res; 1990; 324():59-68. PubMed ID: 2106693
    [No Abstract]   [Full Text] [Related]  

  • 4. Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitors.
    Ehrenforth S; Kreuz W; Funk M; Auerswald G; Scharrer I
    Thromb Haemost; 1994 Nov; 72(5):784-5. PubMed ID: 7900088
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological studies of haemophilic patients with inhibitors treated with Factor VIII concentrates in a protocol to induce immunotolerance.
    Aznar JA; Jorquera JI; Carbonell F; Sánchez-Cuenca JM; Trenor A; De Andrés Medina R; Carmona E; González-Molina A
    Thromb Haemost; 1984 Oct; 52(2):212-3. PubMed ID: 6441305
    [No Abstract]   [Full Text] [Related]  

  • 6. Immune tolerance induction with highly purified plasma-derived factor VIII containing von Willebrand factor in hemophilia A patients with high-responding inhibitors.
    Orsini F; Rotschild C; Beurrier P; Faradji A; Goudemand J; Polack B
    Haematologica; 2005 Sep; 90(9):1288-90. PubMed ID: 16154861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunological and laboratory aspects of immune tolerance.
    Kazatchkine M; Hoyer L
    Vox Sang; 1996; 70 Suppl 1():52-9. PubMed ID: 8869470
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hemophilia A with factor VIII inhibitor].
    Shima M
    Rinsho Ketsueki; 2003 Feb; 44(2):90-101. PubMed ID: 12692981
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune tolerance in hemophilia and treatment of hemophiliacs with an inhibitor.
    Mariani G; Brackmann HH
    Haematologica; 2001 Mar; 86(3):225-6. PubMed ID: 11255267
    [No Abstract]   [Full Text] [Related]  

  • 10. [Porcine factor VIII].
    De Juan MJ; Montoro JB; Tusell JM
    Sangre (Barc); 1991 Jun; 36(3):217-20. PubMed ID: 1948542
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of tolerance using porcine factor VIII.
    Hay CR; Laurian Y
    Vox Sang; 1996; 70 Suppl 1():68-9. PubMed ID: 8869473
    [No Abstract]   [Full Text] [Related]  

  • 12. Factor VIII inhibitors.
    Gilles JG; Jacquemin MG; Saint-Remy JM
    Thromb Haemost; 1997 Jul; 78(1):641-6. PubMed ID: 9198231
    [No Abstract]   [Full Text] [Related]  

  • 13. Induced immunotolerance in factor VIII inhibitor patients.
    Brackmann HH
    Prog Clin Biol Res; 1984; 150():181-95. PubMed ID: 6431426
    [No Abstract]   [Full Text] [Related]  

  • 14. A continuing challenge: treatment of hemophilic children with acquired factor VIII inhibitors.
    Bell BA
    Am J Pediatr Hematol Oncol; 1993 Feb; 15(1):105-6. PubMed ID: 8447549
    [No Abstract]   [Full Text] [Related]  

  • 15. Tolerance and intolerance to factor VIII: a clinical perspective.
    Briët E
    Adv Exp Med Biol; 1995; 386():193-9. PubMed ID: 8851028
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune tolerance to Factor VIII: the international registry data.
    Mariani G; Hilgartner M; Thompson AR; Tusell J; Manco-Johnson M; Ghirardini A; Bellocco R; Brackmann HH
    Adv Exp Med Biol; 1995; 386():201-8. PubMed ID: 8851029
    [No Abstract]   [Full Text] [Related]  

  • 17. Anti-factor VIII antibodies (Inhibitors) in hemophilia A: in dire need of basic and therapeutic research.
    Kaveri SV
    Clin Rev Allergy Immunol; 2009 Oct; 37(2):55-7. PubMed ID: 19153680
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunogenicity and immune tolerance coagulation Factors VIII and IX.
    Rup B
    Dev Biol (Basel); 2003; 112():55-9. PubMed ID: 12762504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure to induce immune tolerance in a hemophilia A patient with high titre titre VIII:C inhibitor.
    Povlsen JV; Møller B; Jacobsen SE; Wallevik K; Zachariae E; Laursen B; Bernvil SS
    Thromb Res; 1989 Jan; 53(1):79-84. PubMed ID: 2466347
    [No Abstract]   [Full Text] [Related]  

  • 20. [Inhibitors against factor VIII in hemophilia. A review of treatment possibilities and personal results].
    Scheibel E; Feddersen C
    Ugeskr Laeger; 1985 Nov; 147(47):3803-7. PubMed ID: 3934824
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.